FDA Inspection 1106178 — Kabco Pharmaceuticals, Inc.

Kabco Pharmaceuticals, Inc. — FEI 2434805

The FDA completed an inspection of Kabco Pharmaceuticals, Inc. on October 4, 2019 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 4, 2019
Fiscal Year
2020
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Amityville, NY (United States)

Citations

IDCFRDescription
1544321 CFR 111.15(b)(2)Physical plant - repair
1545321 CFR 111.16Written procedures - cleaning
1553221 CFR 111.255(b)Batch record - complete
1556821 CFR 111.260(m)Batch record - performance